BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23832526)

  • 21. Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model.
    Huhndorf M; Moussavi A; Kramann N; Will O; Hattermann K; Stadelmann C; Jansen O; Boretius S
    PLoS One; 2016; 11(12):e0168174. PubMed ID: 28005983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker.
    Chen BB; Shih TT
    World J Gastroenterol; 2014 Mar; 20(12):3125-34. PubMed ID: 24695624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of methods for determining vascular permeability and blood volume in human gliomas.
    Harrer JU; Parker GJ; Haroon HA; Buckley DL; Embelton K; Roberts C; Balériaux D; Jackson A
    J Magn Reson Imaging; 2004 Nov; 20(5):748-57. PubMed ID: 15503330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of cerebral tumour blood flow and permeability with T1-weighted dynamic contrast enhanced MRI: a feasibility study.
    Dujardin MI; Sourbron SP; Chaskis C; Verellen D; Stadnik T; de Mey J; Luypaert R
    J Neuroradiol; 2012 Oct; 39(4):227-35. PubMed ID: 21840059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimate of vascular permeability and cerebral blood volume using Gd-DTPA contrast enhancement and dynamic T2*-weighted MRI.
    Cao Y; Shen Z; Chenevert TL; Ewing JR
    J Magn Reson Imaging; 2006 Aug; 24(2):288-96. PubMed ID: 16795091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Permeability of Brain Tumor Vessels Induced by Uniform or Spatially Microfractionated Synchrotron Radiation Therapies.
    Bouchet A; Potez M; Coquery N; Rome C; Lemasson B; Bräuer-Krisch E; Rémy C; Laissue J; Barbier EL; Djonov V; Serduc R
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1174-1182. PubMed ID: 28721902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?
    Brasch RC; Gossmann A; Helbich TH; Kuriyama N; Roberts TP; Shames DM; van Bruggen N; Wendland MF; Israel MA
    Acad Radiol; 2002 Aug; 9 Suppl 2():S326-7. PubMed ID: 12188263
    [No Abstract]   [Full Text] [Related]  

  • 29. [Magnetic resonance imaging with spectroscopy, perfusion and cerebral diffusion in the diagnosis of brain tumours].
    Fayed-Miguel N; Morales-Ramos H; Modrego-Pardo PJ
    Rev Neurol; 2006 Jun 16-30; 42(12):735-42. PubMed ID: 16775800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early changes measured by CT perfusion imaging in tumor microcirculation following radiosurgery in rat C6 brain gliomas.
    Guan LM; Qi XX; Xia B; Li ZH; Zhao Y; Xu K
    J Neurosurg; 2011 Jun; 114(6):1672-80. PubMed ID: 21351829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
    Hsu CC; Watkins TW; Kwan GN; Haacke EM
    J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delineation and segmentation of cerebral tumors by mapping blood-brain barrier disruption with dynamic contrast-enhanced CT and tracer kinetics modeling-a feasibility study.
    Bisdas S; Yang X; Lim CC; Vogl TJ; Koh TS
    Eur Radiol; 2008 Jan; 18(1):143-51. PubMed ID: 17701183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR imaging of tumor microcirculation: promise for the new millennium.
    Taylor JS; Tofts PS; Port R; Evelhoch JL; Knopp M; Reddick WE; Runge VM; Mayr N
    J Magn Reson Imaging; 1999 Dec; 10(6):903-7. PubMed ID: 10581502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.
    Roberts HC; Roberts TP; Brasch RC; Dillon WP
    AJNR Am J Neuroradiol; 2000 May; 21(5):891-9. PubMed ID: 10815665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of 3-dimensional pseudocontinuous arterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonance imaging in grading of human glioma.
    Roy B; Awasthi R; Bindal A; Sahoo P; Kumar R; Behari S; Ojha BK; Husain N; Pandey CM; Rathore RK; Gupta RK
    J Comput Assist Tomogr; 2013; 37(3):321-6. PubMed ID: 23673999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
    Rosen MA; Schnall MD
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Perfusion by magnetic resonance imaging: its physical foundations and clinical application].
    Fayed-Miguel N; Castillo-Blandino J; Medrano-Lin J
    Rev Neurol; 2010 Jan 1-15; 50(1):23-32. PubMed ID: 20073020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
    Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
    Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional susceptibility-weighted imaging at 3 T using various image analysis methods in the estimation of grading intracranial gliomas.
    Hori M; Mori H; Aoki S; Abe O; Masumoto T; Kunimatsu S; Ohtomo K; Kabasawa H; Shiraga N; Araki T
    Magn Reson Imaging; 2010 May; 28(4):594-8. PubMed ID: 20233645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.